{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:45:48Z","timestamp":1790696748175,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109122"],"award-info":[{"award-number":["JP17ek0109122"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109122"],"award-info":[{"award-number":["JP17ek0109122"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109122"],"award-info":[{"award-number":["JP17ek0109122"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17ek0109122"],"award-info":[{"award-number":["JP17ek0109122"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center for Global Health and Medicine","award":["27-1402"],"award-info":[{"award-number":["27-1402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12020-021-02816-9","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T20:02:30Z","timestamp":1626465750000},"page":"155-162","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"Akiyuki","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-7529","authenticated-orcid":false,"given":"Masakatsu","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Tsuiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Ichijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanobu","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"2816_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"J.W. Lenders, G. Eisenhofer, M. Mannelli, K. Pacak,, Pheochromocytoma. Lancet. 366, 665\u2013675 (2005). https:\/\/doi.org\/10.1016\/S0140-6736(05)67139-5","journal-title":"Lancet."},{"key":"2816_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","volume":"51","author":"AMA Berends","year":"2018","unstructured":"A.M.A. Berends, E. Buitenwerf, R.R. de Krijger, N.J.G.M. Veeger, A.N.A. van der Horst-Schrivers, T.P. Links, M.N. Kerstens,, Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review. Eur. J. Intern. Med. 51, 68\u201373 (2018). https:\/\/doi.org\/10.1016\/j.ejim.2018.01.015","journal-title":"Eur. J. Intern. Med."},{"issue":"6","key":"2816_CR3","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","volume":"83","author":"G Eisenhofer","year":"1998","unstructured":"G. Eisenhofer, H. Keiser, P. Friberg, E. Mezey, T.T. Huynh, B. Hiremagalur, T. Ellingson, S. Duddempudi, A. Eijsbouts, J.W. Lenders, Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J. Clin. Endocrinol. Metab. 83(6), 2175\u20132185 (1998). https:\/\/doi.org\/10.1210\/jcem.83.6.4870","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2816_CR4","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"J.W. Lenders, Q.Y. Duh, G. Eisenhofer, A.P. Gimenez-Roqueplo, S.K.G. Grebe, M.H. Murah, M. Naruse, K. Pacak, W.F. Young Jr., Endocrine society. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(6), 1915\u20131942 (2014). https:\/\/doi.org\/10.1210\/jc.2014-1498","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2816_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/jso.24031","volume":"112","author":"MG Heavner","year":"2015","unstructured":"M.G. Heavner, L.S. Krane, S.M. Winters, M. Mirzazadeh, Pheochromocytoma diagnosed pathologically with previous negative serum markers. J. Surg. Oncol. 112(5), 492\u2013495 (2015). https:\/\/doi.org\/10.1002\/jso.24031","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"2816_CR6","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.surg.2009.09.013","volume":"146","author":"KA Vanderveen","year":"2009","unstructured":"K.A. Vanderveen, S.M. Thompson, M.R. Callstrom, W.F. Young Jr, C.S. Grant, D.R. Farley, M.L. Richards, G.B. Thompson, Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery 146(6), 1158\u20131166 (2009). https:\/\/doi.org\/10.1016\/j.surg.2009.09.013","journal-title":"Surgery"},{"issue":"11","key":"2816_CR7","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","volume":"287","author":"JW Lenders","year":"2002","unstructured":"J.W. Lenders, K. Pacak, M.M. Walther, W.M. Linehan, M. Mannelli, P. Friberg, H.R. Keiser, D.S. Goldstein, G. Eisenhofer, Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287(11), 1427\u20131434 (2002). https:\/\/doi.org\/10.1001\/jama.287.11.1427","journal-title":"JAMA"},{"issue":"11","key":"2816_CR8","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","volume":"64","author":"G Eisenhofer","year":"2018","unstructured":"G. Eisenhofer, A. Prejbisz, M. Peitzsch, C. Pamporaki, J. Masjkur, N. Rogowski-Lehmann, K. Langton, E. Tsourdi, M. P\u0119czkowska, S. Fliedner, T. Deutschbein, F. Megerle, H.J.L.M. Timmers, R. Sinnott, F. Beuschlein, M. Fassnacht, A. Januszewicz, J.W.M. Lenders, Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-Methylated Catecholamine metabolites. Clin. Chem. 64(11), 1646\u20131656 (2018). https:\/\/doi.org\/10.1373\/clinchem.2018.291369","journal-title":"Clin. Chem."},{"issue":"9","key":"2816_CR9","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"O. Hamidi, W.F. Young Jr, N.M. I\u00f1iguez-Ariza, N.E. Kittah, L. Gruber, C. Bancos, S. Tamhane, I. Bancos, Malignant pheochromocytoma and paraganglioma:272 patients over 55 years. J. Clin. Endocrinol. Metab. 102(9), 3296\u20133305 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2816_CR10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.juro.2010.12.050","volume":"185","author":"F Feng","year":"2011","unstructured":"F. Feng, Y. Zhu, X. Wang, Y. Wu, W. Zhou, X. Jin, R. Zhang, F. Sun, Z. Kasoma, Z. Shen, Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J. Urol. 185(5), 1583\u20131590 (2011). https:\/\/doi.org\/10.1016\/j.juro.2010.12.050","journal-title":"J. Urol."},{"issue":"17","key":"2816_CR11","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"A.P. Gimenez-Roqueplo, J. Favier, P. Rustin, C. Rieubland, M. Crespin, V. Nau, P. Khau Van Kien, P. Corvol, P.F. Plouin, X. Jeunemaitre, COMETE network.: mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 63(17), 5615\u20135621 (2003)","journal-title":"Cancer Res."},{"issue":"34","key":"2816_CR12","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"L. Amar, J. Bertherat, E. Baudin, C. Ajzenberg, B. Bressac-de Paillerets, O. Chabre, B. Chamontin, B. Delemer, S. Giraud, A. Murat, P. Niccoli-Sire, S. Richard, V. Rohmer, J.L. Sadoul, L. Strompf, M. Schlumberger, X. Bertagna, P.F. Plouin, X. Jeunemaitre, A.P. Gimenez-Roqueplo, Genetic testing in pheochromocytoma or functional paraganglioma. J. Clin. Oncol. 23(34), 8812\u20138818 (2005). https:\/\/doi.org\/10.1200\/JCO.2005.03.1484","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"2816_CR13","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1210\/jc.2008-1093","volume":"93","author":"HJ Timmers","year":"2008","unstructured":"H.J. Timmers, K. Pacak, T.T. Huynh, M. Abu-Asab, M. Tsokos, M.J. Merino, B.E. Baysal, K.T. Adams, G. Eisenhofer, Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J. Clin. Endocrinol. Metab. 93(12), 4862\u20134832 (2008). https:\/\/doi.org\/10.1210\/jc.2008-1093","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2816_CR14","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.1210\/jc.2019-00202","volume":"104","author":"KMA Dreijerink","year":"2019","unstructured":"K.M.A. Dreijerink, J.A. Rijken, C.J. Compaijen, H.J.L.M. Timmers, A.N.A. van der Horst-Schrivers, R.S. van Leeuwaarde, P.S. van Dam, C.R. Leemans, E.W.C.M. van Dam, C. Dickhoff, C.J. Dommering, P. de Graaf, G.J.C. Zwezerijnen, P. van der Valk, C.W. Menke-Van der Houven van Oordt, E.F. Hensen, E.P.M. Corssmit, E.M.W. Eekhoff, Biochemically silent sympathetic paraganglioma, pheochromocytoma, or metastatic disease in SDHD mutation carriers. J. Clin. Endocrinol. Metab. 104(11), 5421\u20135426 (2019). https:\/\/doi.org\/10.1210\/jc.2019-00202","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2816_CR15","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"H.P. Neumann, C. Pawlu, M. Peczkowska, B. Bausch, S.R. McWhinney, M. Muresan, M. Buchta, G. Franke, J. Klisch, T.A. Bley, S. Hoegerle, C.C. Boedeker, G. Opocher, J. Schipper, A. Januszewicz, C. Eng; European-American Paraganglioma Study Group, Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292(8), 943\u2013951 (2004). https:\/\/doi.org\/10.1001\/jama.292.8.943","journal-title":"JAMA"},{"issue":"9","key":"2816_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/jnci\/djs188","volume":"104","author":"HJ Timmers","year":"2012","unstructured":"H.J. Timmers, C.C. Chen, J.A. Carrasquillo, M. Whatley, A. Ling, G. Eisenhofer, K.S. King, J.U. Rao, R.A. Wesley, K.T. Adams, K. Pacak, Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J. Natl. Cancer Inst. 104(9), 700\u2013708 (2012). https:\/\/doi.org\/10.1093\/jnci\/djs188","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"2816_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4111\/kju.2011.52.4.241","volume":"52","author":"J Park","year":"2011","unstructured":"J. Park, C. Song, M. Park, S. Yoo, S.J. Park, S. Hong, B. Hong, C.S. Kim, H. Ahn, Predictive characteristics of malignant pheochromocytoma. Korean J. Urol. 52(4), 241\u2013246 (2011). https:\/\/doi.org\/10.4111\/kju.2011.52.4.241","journal-title":"Korean J. Urol."},{"issue":"5","key":"2816_CR18","doi-asserted-by":"publisher","first-page":"e0125426","DOI":"10.1371\/journal.pone.0125426","volume":"10","author":"E Grouzmann","year":"2015","unstructured":"E. Grouzmann, O. Tschopp, F. Triponz, M. Matter, S. Bilz, M. Br\u00e4ndle, T. Drechser, S. Sigrist, H. Zulewski, C. Henzen, S. Fischli, K. Abid, Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites? PLoS ONE 10(5), e0125426 (2015). https:\/\/doi.org\/10.1371\/journal.pone.0125426","journal-title":"PLoS ONE"},{"issue":"11","key":"2816_CR19","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"G. Eisenhofer, J.W. Lenders, G. Siegert, S.R. Bornstein, P. Friberg, D. Milosevic, M. Mannelli, W.M. Linehan, K. Adams, H.J. Timmers, K. Pacak, Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur. J. Cancer 48(11), 1739\u20131749 (2012). https:\/\/doi.org\/10.1016\/j.ejca.2011.07.016","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"2816_CR20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"G. Eisenhofer, M.M. Walther, T.T. Huynh, S.T. Li, S.R. Bornstein, A. Vortmeyer, M. Mannelli, D.S. Goldstein, W.M. Linehan, J.W. Lenders, K. Pacak, Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J. Clin. Endocrinol. Metab. 86(5), 1999\u20132008 (2001). https:\/\/doi.org\/10.1210\/jcem.86.5.7496","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2816_CR21","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJLM Timmers","year":"2009","unstructured":"H.J.L.M. Timmers, C.C. Chen, J.A. Carrasquillo, M. Whatley, A. Ling, B. Havekes, G. Eisenhofer, L. Martiniova, K.T. Adams, K. Pacak, Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the localization of pheochromocytoma and paraganglioma. J. Clin. Endocrinol. Metab. 94(12), 4757\u20134767 (2009). https:\/\/doi.org\/10.1210\/jc.2009-1248","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2816_CR22","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2967\/jnumed.108.052373","volume":"49","author":"I Ilias","year":"2008","unstructured":"I. Ilias, C.C. Chen, J.A. Carrasquillo, M. Whatley, A. Ling, K.T. Adams, S. Perera, K. Pacak, Comparison of 6-18F-Fluorodopamine PET with 123I-Metaiodobenzylguanidine and 111In-Pentetreotide scintigraphy in localization of nonmetastatic and metastatic pheochromocytoma. J. Nucl. Med. 49(10), 1613\u20131619 (2008). https:\/\/doi.org\/10.2967\/jnumed.108.052373","journal-title":"J. Nucl. Med."},{"issue":"1","key":"2816_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3803\/EnM.2020.35.1.157","volume":"35","author":"JH Kim","year":"2020","unstructured":"J.H. Kim, H. Moon, J. Noh, J. Lee, S.G. Kim, Epidemiology and prognosis of pheochromocytoma\/paraganglioma in Korea: a nationwide study based on the national health insurance service. Endocrinol. Metab. 35(1), 157\u2013164 (2020). https:\/\/doi.org\/10.3803\/EnM.2020.35.1.157","journal-title":"Endocrinol. Metab."},{"issue":"2","key":"2816_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","volume":"40","author":"SM Zuber","year":"2011","unstructured":"S.M. Zuber, V. Kantorovich, K. Pacak, Hypertension in pheochromocytoma: characteristics and treatment. Endocrinol. Metab. Clin. North Am. 40(2), 295\u2013311 (2011). https:\/\/doi.org\/10.1016\/j.ecl.2011.02.002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"9","key":"2816_CR25","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2017-00357","volume":"102","author":"H Komada","year":"2017","unstructured":"H. Komada, Y. Hirota, A. So, T. Nakamura, Y. Okuno, H. Fukuoka, G. Iguchi, Y. Takahashi, K. Sakaguchi, W. Ogawa, Insulin secretion and insulin sensitivity before and after surgical treatment of pheochromocytoma or paraganglioma. J. Clin. Endocrinol. Metab. 102(9), 3400\u20133405 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00357","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2816_CR26","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1210\/jc.2012-3625","volume":"98","author":"O Petr\u00e1k","year":"2013","unstructured":"O. Petr\u00e1k, D. Haluz\u00edkov\u00e1, P. Kav\u00e1lkov\u00e1, B. \u0160trauch, J. Rosa, R. Holaj, A. Brabcov\u00e1 Vr\u00e1nkov\u00e1, D. Michalsky, M. Haluz\u00edk, T. Zelinka, J. Widimsky Jr., Changes in energy metabolism in pheochromocytoma. J. Clin. Endocrinol. Metab. 98(4), 1651\u20131658 (2013). https:\/\/doi.org\/10.1210\/jc.2012-3625","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2816_CR27","volume-title":"WHO classification of tumours: pathology and genetics of tumours of endocrine organs","author":"RV Lloyd","year":"2017","unstructured":"R.V. Lloyd, R.Y. Osamura, G. Kloppel, J. Rosai, WHO classification of tumours: pathology and genetics of tumours of endocrine organs. 4th ed. (IARC, Lyon), 2017)","edition":"4th ed."},{"key":"2816_CR28","doi-asserted-by":"publisher","unstructured":"A.K. Lam, Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr. Pathol. 28(3), 213\u2013227 (2017). https:\/\/doi.org\/10.1007\/s12022-017-9484-5","DOI":"10.1007\/s12022-017-9484-5"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T09:34:21Z","timestamp":1631612061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02816-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All studies analyzed in the present study were in accordance with the Declaration of Helsinki and the guidelines for clinical studies published by the Ministry of Health and Labour, Japan and were approved by the Ethics Committee of the National Hospital Organization Kyoto Medical Center as the project-leading center and by the institutional ethics committees of the participating centers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}